CVI-VZV-001

BIOLOGICAL2 trials

Sponsors

CHA Vaccine Institute Co., Ltd.

Conditions

Herpes ZosterVaccine-Preventable Diseases

Phase 1

Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above

RecruitingNCT06137755

CHA Vaccine Institute Co., Ltd.Herpes Zoster, Vaccine-Preventable Diseases

Start: 2023-03-15End: 2025-03-21Target: 32Updated: 2024-11-19

Phase 2

Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above

Not yet recruitingNCT07481604

CHA Vaccine Institute Co., Ltd.Herpes Zoster

Start: 2026-04-01End: 2027-01-01Target: 135Updated: 2026-03-19